The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Functional expression and localization of P‐glycoprotein at the blood brain barrier
Open accessAbstract
Until recently, the blood‐brain barrier was viewed as a static lipid membrane barrier. Physical attributes of the cerebral endothelial cells such as the presence of tight junctions, paucity of vesicles or caveolae, and high electrical resistance were believed to be the primary components that provide the membrane selectivity of the blood‐brain barrier to a variety of circulating compounds from the periphery. However, results from molecular biology, immunocytochemistry, biochemistry, and transport studies show that the cerebral endothelial cells possess an asymmetrical array of metabolic enzymes (i.e., alkaline phosphatase, cytochrome P450 enzymes, glutathione transferases) and energy‐dependent efflux transport proteins (i.e., P‐glycoprotein and Multidrug‐resistance proteins) that are instrumental to the barrier function. P‐glycoprotein, a membrane‐associated, energy‐dependent, efflux transporter, is expressed in brain parenchyma (i.e., astrocytes and microglia) as well as in blood‐brain and blood‐cerebrospinal fluid barriers. Its function along the blood‐brain barrier is believed to prevent the accumulation of potentially harmful compounds in the brain by actively removing them from the brain into the peripheral circulation. This is a brief review on the expression and activity of P‐glycoprotein at the blood‐brain barrier, which reports on the localization of the protein in rat brain capillaries in situ as well as in a well‐characterized in vitro model of the blood‐brain barrier, an immortalized rat brain endothelial cell line, the RBE4. Immunocytochemical analysis employing various P‐glycoprotein monoclonal antibodies, demonstrated the presence of the protein along the plasma membrane, in plasmalemmal vesicles and nuclear envelope of rat cerebral endothelial cells, both in situ and in vitro. Western blot analysis revealed a single band with a molecular weight of 170–180 kDa, a size previously reported for P‐glycoprotein, in RBE4 cells. In addition, results from functional studies show that the accumulation of the P‐glycoprotein substrate digoxin by RBE4 monolayer cells is significantly enhanced in the presence of standard P‐glycoprotein inhibitors (verapamil, cyclosporin A, PSC 833), protease inhibitors (saquinavir, ritonavir, indinavir), and the metabolic inhibitor, sodium azide. These results demonstrate the functional expression of P‐glycoprotein in the immortalized rat brain endothelial cell line, RBE4. Novel in situ and in vitro intracellular locations of P‐glycoprotein in cerebral endothelial cells have been identified suggesting that this transporter may play a significant role in the subcellular distribution of substrates in the brain. Microsc. Res. Tech. 57:365–380, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE
Reese, T. S., & Karnovsky, M. J. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.34.1.207 · Cited by 2,629
Pardridge, W. M., Boado, R. J., & Farrell, C. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38267-x · Cited by 606 · cited 4×
“However, it is now well established that the brain permeability of a number of highly lipophilic compounds such as vincristine, doxorubicin and cyclosporine A is unexpectedly low (Pardridge et al., 1990; Tsuji, 2000).”
BackgroundInfluentialCarrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids
Oldendorf, W. (1973) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1973.224.6.1450 · Cited by 463 · cited 1×
“…information into the transport properties of amino acids (Betz and Goldstein, 1978), glucose (Pardridge et al., 1990), monocarboxylic acids (Oldendorf, 1973), choline (Estrada et al., 1990), nucleosides (Cornford and Oldendorf, 1975), neurotransmitters (Hardebo et al., 1979), as well as a…”
BackgroundCerebrovascular Permeability Coefficients to Sodium, Potassium, and Chloride
Smith, Q. R., & Rapoport, S. I. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb08491.x · Cited by 196
Cited by
Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,406
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Hu, C.-M. J., & Zhang, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.008 · Cited by 686
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 617
Waterhouse, R. (2003) · Molecular Imaging & Biology · doi:10.1016/j.mibio.2003.09.014 · Cited by 567
Nanotechnological advances for the delivery of cns therapeutics.
Wong, H. L., Wu, X. Y., & Bendayan, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.007 · Cited by 488
Self-citation
Metadata
- Authors
- Bendayan, R., Lee, G., & Bendayan, M.
- Venue
- Microscopy Research and Technique
- Publisher
- Wiley
- Published
- 2002-05-22
- Volume
- 57
- Issue
- 5
- Pages
- 365-380
- ISSN
- 1059-910X (ISSN-L)
- 1097-0029
- OpenAlex
- W1977073394
- Cited by
- 187
- References
- 4
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Functional expression and localization of P‐glycoprotein at the blood brain barrier. https://app.cochat.ai/papers/10.1002/jemt.10090
- The paper
- Bendayan, R., Lee, G., & Bendayan, M. (2002). Functional expression and localization of P‐glycoprotein at the blood brain barrier. Microscopy Research and Technique. https://doi.org/10.1002/jemt.10090
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.